Health Technology · Pharmaceuticals: Major · NSE: ZYDUSLIFE · data 2026-10-09

Zydus Lifesciences Limited

Health check: Strong (7.6/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,117.5

Market cap

₹1,11,242 cr

P/E

24.9

P/B

—

ROE

19.7%

ROCE

17.8%

Debt / equity

0.46

Dividend yield

0.09%

1-year return

12.5%

52-week high

₹1,232.1

52-week low

₹835.5

Operating margin

18.6%

Growth

Revenue (last 12 months)	₹28,592 cr
Net profit (last 12 months)	₹4,513 cr
Sales growth, 3 years (yearly)	16.6%
Profit growth, 3 years (yearly)	37.0%

Similar companies

Torrent Pharmaceuticals Ltd (TORNTPHARM) · Laurus Labs Ltd. (LAURUSLABS) · Mankind Pharma Ltd. (MANKIND) · Dr. Reddy's Laboratories Ltd. (DRREDDY) · Alkem Laboratories Ltd. (ALKEM)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ZYDUSLIFE in NSE Scanner →